Reuters logo
BRIEF-Matrix Capital reports 12.9 pct passive stake in Adaptimmune Therapeutics
September 11, 2017 / 12:34 PM / 3 months ago

BRIEF-Matrix Capital reports 12.9 pct passive stake in Adaptimmune Therapeutics

Sept 11 (Reuters) - Matrix Capital Management Co Lp:

* Matrix Capital Management Company Lp reports 12.9 percent passive stake in Adaptimmune Therapeutics Plc as of August 31, 2017 - SEC filing Source text: (bit.ly/2wSEc1U)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below